首页> 外国专利> IMPLANTED NEURO-ENDOPROSTHESIS SYSTEM, METHOD FOR ITS OBTAINING AND METHOD FOR CARRYING OUT A RECONSTRUCTIVE NEUROSURGICAL OPERATION

IMPLANTED NEURO-ENDOPROSTHESIS SYSTEM, METHOD FOR ITS OBTAINING AND METHOD FOR CARRYING OUT A RECONSTRUCTIVE NEUROSURGICAL OPERATION

机译:植入式神经内固定系统,获得方法及进行重建性神经外科手术的方法

摘要

1. An implantable neuroendoprosthetic system for replacing defects in the brain and spinal cord and the autonomic nervous system of a mammal during reconstructive neurosurgical operations, which is an elastically elastic cell-biopolymer biologically active mass obtained from a heterogeneous collagen-containing matrix for implantation and biocomposition of autologous patient cells from various cell types of cell preparations from various cell preparations. ! 2. The implantable system according to claim 1, characterized in that the biocomposition contains in the NaCl solution neural stem cells (NSC), neuroglial parietal cells (NGOK), endothelial cells with a marker CD34 + (EC) and purified mononuclear cells (MN) in the following ratio components (in parts by the number of cells): NSC - 0.8-1.2; NGOK - 1.6-2.4; EC - 4-6; MN - 4000-6000. ! 3. The implantable system according to claim 2, characterized in that a 0.5-1.3% NaCl solution is used. ! 4. The implantable system according to claim 1, characterized in that the composition of the heterogeneous implantable gel "Sphero® GEL" is used as a heterogeneous collagen-containing matrix. ! 5. The implantable system according to any one of claims 1 to 4, characterized in that it contains the following number of cells in 0.5-1 ml of 0.9% NaCl solution based on 1 ml of heterogeneous collagen-containing matrix: NSC - 106; NGOK - 2 · 106; EC - 5 · 106; MH -5109. ! 6. The implantable system according to claim 1, characterized in that the biocomposition further comprises stimulators of cell regeneration and growth factors of nerves and blood vessels. ! 7. A method of obtaining an implantable neuroendoprosthetic system for replacing defects in the brain and spinal cord and the autonomic nervous system of a mammalian
机译:1.一种可植入的神经内膜系统,用于在重建神经外科手术期间替换哺乳动物的脑和脊髓以及植物神经系统的缺陷,该系统是一种弹性的细胞生物聚合物的生物活性物质,该物质是从含胶原的异质基质中植入并植入的。来自各种细胞制备物的各种细胞类型的自体患者细胞的生物组成。 ! 2.根据权利要求1所述的可植入系统,其特征在于,所述生物组合物在NaCl溶液中包含神经干细胞(NSC),神经胶质顶细胞(NGOK),具有标记CD34 +的内皮细胞(EC)和纯化的单核细胞(MN)。 )中的以下比例成分(以细胞数为单位):NSC-0.8-1.2; NGOK-1.6-2.4; EC-4-6; MN-4000-6000。 ! 3.根据权利要求2所述的可植入系统,其特征在于,使用0.5-1.3%的NaCl溶液。 ! 4.根据权利要求1所述的可植入系统,其特征在于,所述异质可植入凝胶“ GEL”的组合物用作异质含胶原的基质。 ! 5.根据权利要求1至4中任一项所述的可植入系统,其特征在于,基于1ml含异质胶原的基质,其在0.5-1ml的0.9%NaCl溶液中包含以下数目的细胞:NSC-106; NSC-106。 NGOK-2·106; EC-5·106; MH -5109。 ! 6.根据权利要求1所述的可植入系统,其特征在于,所述生物组合物还包含细胞再生和神经和血管生长因子的刺激物。 ! 7.一种获得用于代替哺乳动物的脑和脊髓中的缺陷的植入式神经内膜系统的方法,以及哺乳动物的自主神经系统。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号